Introduction Prior studies demonstrated marked increases in Clostridium difficile infection
(CDI) in the United States (US) in recent years. The objective of this study was to describe …

Background Current practice guidelines favour fidaxomicin over vancomycin and exclude
metronidazole from the recommended standard regimen for Clostridioides difficile infection …

Abstract Background In 2018, the Infectious Diseases Society of America (IDSA) published
guidelines for diagnosis and treatment of Clostridioides (formerly Clostridium) difficile …

Abstract Background Recurrent Clostridium difficile infection (rCDI) is observed in up to 25%
of patients with an initial CDI episode (iCDI). We assessed risk factors for rCDI among …

Background Prior studies have demonstrated an increase in Clostridium difficile infection
(CDI) incidence in the United States (US) in recent years, but trends among different age …

Background Many administrative data sources are available to study the epidemiology of
infectious diseases, including Clostridium difficile infection (CDI), but few publications have …

ObjectiveA significant portion of patients with Clostridium difficile infections (CDI) experience
recurrence, and there is little consensus on its treatment. With the availability of newer …

Objective. To determine the attributable in-hospital mortality, length of stay (LOS), and cost of
hospital-onset Clostridium difficile infection (HO-CDI). Design. Propensity score matching …

Abstract Background. The incidence of Clostridium difficile–associated disease (CDAD) is
increasing. There are few data on the short-term and long-term attributable costs of CDAD …

Few studies have evaluated the mortality or quantified the economic burden of community-
onset Clostridium difficile infection (CDI). We estimated the attributable mortality and costs of …